Can fido fetch the fountain of youth?

May 15, 2018 by Serena Gordon, Healthday Reporter
Photo: Robin Foster

(HealthDay)—Humanity's search for a fountain of youth stretches back centuries, but modern scientists hope new research in dogs might be barking up the right tree.

The Dog Aging Project is looking at a known as rapamycin, which is already approved by the U.S. Food and Drug Administration for use in people with cancer or who've had organ transplants.

One known action of the drug is to suppress the immune system, according to the U.S. National Cancer Institute. But paradoxically, a study by drug maker Novartis also found rapamycin appeared to boost the immune function of folks aged 65 and older.

Although it may not be clear how the drug works, know the medication has extended the lives of yeast, flies and worms by about 25 percent. It has also lengthened the lives of mice, even when given at older ages, the researchers noted.

In , the researchers now hope to add about 20 percent more to the animals' ball-chasing time on Earth.

What about humans? Right now, Matt Kaeberlein, leader of the Dog Aging Project, said, "It's complete speculation, but with something like rapamycin, we might get 10 to 15, maybe as much as 20 years. And in most people, they would be healthy additional years."

He explained that it's harder to compare the life spans of humans and mice, but he expects to get a "much better feel for overall health from dogs than in mice." But research on animals often does not produce the same results in humans.

Kaeberlein is co-director of the University of Washington Medicine's Nathan Shock Center of Excellence in the Basic Biology of Aging.

Dogs age in a similar manner to humans, just faster, he explained. Dogs age about seven times faster than humans do, with large dogs aging even faster, he said. So, researchers can follow the dogs for their whole life span, to see if an intervention is able to slow aging.

Dogs also offer the advantage of living in the same environments as people do. "That's just not something we can capture in lab studies," Kaeberlein said.

Kaeberlein and his team's first study included 40 dogs from the Seattle area. The main purpose was to make sure the drug was safe. These are people's pets, after all, Kaeberlein said. Sixteen pets were excluded because they had underlying health conditions, although they had no outward symptoms.

The researchers gave a deliberately low dose of the drug or a placebo to the 24 participating dogs for 10 weeks. The pooches weighed at least 40 to 50 pounds and all were middle-aged (more than 6 years old), Kaeberlein said.

The study was double-blinded. That means neither the researchers nor the pet parents knew which dogs got the drug and which got the placebo.

Kaeberlein said there were virtually no side effects from the drug, and that heart function appeared to improve in the dogs given the drug. He added that the dogs that seemed to benefit the most were those that had lower heart function going into the study.

People whose dogs received the drug said their pets had more energy and were more affectionate. But at the time they answered the survey, they had no way of knowing if their dog had received the drug or not.

Kaeberlein cautioned that while the findings are hopeful, this is a small study that needs to be replicated.

In doses used to suppress the immune system after an organ transplant, rapamycin has been linked to an increased risk of type 2 diabetes. Kaeberlein said the researchers tested in the dog and didn't find evidence of higher blood sugar.

The researchers are already actively enrolling dogs in the next study that will look at , activity, thinking and memory. This study will include 50 dogs.

They're also planning a larger trial of the drug to begin in 2019, but it's currently just in the planning stages. The researchers are also planning a longitudinal study to follow a large group of dogs—about 10,000—over a long period (at least five years, but hopefully 10 to 15) to understand the biological and environmental factors that influence aging in dogs.

Kaeberlein said that, in addition to rapamycin, there are a number of other interventions that may be able to extend aging, including metformin and acarbose, two drugs used to treat type 2 diabetes.

Explore further: Brief rapamycin therapy in middle-aged mice extends lives

More information: May 11, 2018, webinar with Matt Kaeberlein, Ph.D., co-director, University of Washington Medicine's Nathan Shock Center of Excellence in the Basic Biology of Aging, Seattle

Get tips on healthy aging from PBS's NextAvenue website.

Related Stories

Brief rapamycin therapy in middle-aged mice extends lives

August 23, 2016
Geroscience researchers studying the biology of aging briefly treated middle-aged mice with the drug rapamycin to gauge the long-term effects of short-term therapy on health and longevity.

Companion dogs provide a unique translational model for human health studies

March 7, 2018
Dogs are commonly referred to as man's best friend. This is because of their undeniable physical and emotional connection to their owners. Now, new research suggests that this connection is actually closer than had previously ...

New chimeric antibody that suppresses malignant cancers in dogs

August 25, 2017
Similar to humans, dogs live longer than before and an increasing number of them die from cancer. As seen in humans, dogs have malignant cancers that cannot be treated by existing therapies such as surgery, radiotherapy and ...

Are you barking up the wrong tree by sleeping with your dog?

September 7, 2017
Let sleeping dogs lie ... in the bedroom. That's according to a new Mayo Clinic study that's sure to set many tails wagging.

Recommended for you

Parental life span predicts daughters living to 90 without chronic disease or disability

August 15, 2018
Researchers at the University of California San Diego School of Medicine report that women whose mothers lived to at least age 90 were more likely to also live to 90, free of serious diseases and disabilities.

Can sleeping too much lead to an early death?

August 15, 2018
A recent study in the Journal of the American Heart Association has led to headlines that will make you rethink your Saturday morning sleep in.

Diets high in vegetables and fish may lower risk of multiple sclerosis

August 15, 2018
People who consume a diet high in vegetables and fish may have a reduced risk of multiple sclerosis, new research led by Curtin University has found.

Eating breakfast burns more carbs during exercise and accelerates metabolism for next meal

August 15, 2018
Eating breakfast before exercise may "prime" the body to burn carbohydrates during exercise and more rapidly digest food after working out, University of Bath researchers have found.

Mixing energy drinks with alcohol could enhance the negative effects of binge drinking

August 14, 2018
A key ingredient of energy drinks could be exacerbating some of the negative effects of binge drinking according to a new study.

New study finds fake, low-quality medicines prevalent in the developing world

August 10, 2018
A new study from the University of North Carolina at Chapel Hill found that substandard and falsified medicines, including medicines to treat malaria, are a serious problem in much of the world. In low- and middle-income ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.